# Upstream Bio, Inc.: filings

UPB · Nasdaq · CIK 2022626 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/upb.md) · [Financials](/companies/upb/financials.md) · [Filings](/companies/upb/filings.md) · [Insiders](/companies/upb/insiders.md)

## Reports and events: 30 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 48, 8-K 16, 3 14, SCHEDULE 13G/A 7, 10-Q 6, SCHEDULE 13G 5, CORRESP 4, S-8 3, UPLOAD 3, 10-K 2, ARS 2, DEF 14A 2, DEFA14A 2, DRS/A 2, DRSLTR 2, SC 13D 2, SC 13G 2, SEC STAFF LETTER 2, 424B4 1, 424B5 1, 8-A12B 1, CERT 1, DRS 1, EFFECT 1, S-1 1, S-1/A 1, S-1MEF 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-01 | 07:05 ET | [8-K](/filings/0001193125-26-377485.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-377485 |
| 2026-08-11 | 07:10 ET | [10-Q](/filings/0001193125-26-343417.md) | Quarterly report, period 2026-06-30 | 0001193125-26-343417 |
| 2026-08-11 | 07:05 ET | [8-K](/filings/0001193125-26-343407.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-343407 |
| 2026-06-10 | 16:05 ET | [8-K](/filings/0001193125-26-265800.md) | 5.07 Shareholder vote results | 0001193125-26-265800 |
| 2026-05-13 | 07:10 ET | [10-Q](/filings/0001193125-26-220584.md) | Quarterly report, period 2026-03-31 | 0001193125-26-220584 |
| 2026-05-13 | 07:05 ET | [8-K](/filings/0001193125-26-220578.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-220578 |
| 2026-04-16 | 16:05 ET | [DEF 14A](/filings/0001193125-26-158966.md) | Proxy statement, period 2026-06-09 | 0001193125-26-158966 |
| 2026-03-26 | 17:09 ET | [8-K](/filings/0001193125-26-126572.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-126572 |
| 2026-03-26 | 16:04 ET | [10-K](/filings/0001193125-26-126188.md) | Annual report, period 2025-12-31 | 0001193125-26-126188 |
| 2026-03-26 | 07:05 ET | [8-K](/filings/0001193125-26-125057.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-125057 |
| 2026-02-11 | 09:17 ET | [8-K](/filings/0001193125-26-045649.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-045649 |
| 2026-02-11 | 06:38 ET | [8-K](/filings/0001193125-26-045500.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-045500 |
| 2025-11-05 | 07:10 ET | [10-Q](/filings/0001193125-25-265713.md) | Quarterly report, period 2025-09-30 | 0001193125-25-265713 |
| 2025-11-05 | 07:05 ET | [8-K](/filings/0001193125-25-265705.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265705 |
| 2025-09-02 | 08:38 ET | [8-K](/filings/0002022626-25-000005.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0002022626-25-000005 |
| 2025-08-06 | 07:12 ET | [10-Q](/filings/0000950170-25-103534.md) | Quarterly report, period 2025-06-30 | 0000950170-25-103534 |
| 2025-08-06 | 07:05 ET | [8-K](/filings/0000950170-25-103528.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-103528 |
| 2025-06-12 | 16:18 ET | [8-K](/filings/0000950170-25-085374.md) | 5.07 Shareholder vote results | 0000950170-25-085374 |
| 2025-05-06 | 07:10 ET | [10-Q](/filings/0000950170-25-063957.md) | Quarterly report, period 2025-03-31 | 0000950170-25-063957 |
| 2025-05-06 | 07:05 ET | [8-K](/filings/0000950170-25-063954.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063954 |
| 2025-04-17 | 16:05 ET | [DEF 14A](/filings/0000950170-25-055372.md) | Proxy statement, period 2025-06-10 | 0000950170-25-055372 |
| 2025-03-12 | 07:10 ET | [10-K](/filings/0000950170-25-037621.md) | Annual report, period 2024-12-31 | 0000950170-25-037621 |
| 2025-03-12 | 07:05 ET | [8-K](/filings/0000950170-25-037619.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-037619 |
| 2024-11-07 | 07:17 ET | [10-Q](/filings/0000950170-24-122793.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122793 |
| 2024-11-07 | 07:10 ET | [8-K](/filings/0000950170-24-122784.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122784 |
| 2024-10-22 | 16:06 ET | [SC 13D](/filings/0001193125-24-241045.md) | Ownership report, active investor | 0001193125-24-241045 |
| 2024-10-17 | 16:16 ET | [SC 13D](/filings/0000947871-24-000805.md) | Ownership report, active investor | 0000947871-24-000805 |
| 2024-10-15 | 16:05 ET | [8-K](/filings/0001193125-24-237580.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-237580 |
| 2024-10-07 | 06:08 ET | [S-1/A](/filings/0001193125-24-233296.md) | Registration statement, amended | 0001193125-24-233296 |
| 2024-09-18 | 16:06 ET | [S-1](/filings/0001193125-24-221372.md) | Registration statement | 0001193125-24-221372 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:14 ET. No prices; not investment advice.